GLOOM
-
Anxiety, data visualization, depression, digital mental health, digital navigator, digital phenotyping, GAD-7, mindLAMP, PHQ-9, Psychology, shared decision making, therapyDigital Mental Health Visualizations: 6 Tools for Anxiety, Depression
A 2026 participatory-design and case-study paper turned smartphone mental-health data into 6…
-
Anxiety, childhood anxiety, default mode network, dmn, dna methylation, epigenetics, fMRI, genetics, GUSTO cohort, limbic network, MASC-2, neuroscience, Psychiatry, Psychology, sex differencesChildhood Anxiety Linked to DNA Methylation and DMN-Limbic Development
A 2026 Singapore birth-cohort preprint found a conditional childhood-anxiety signal: the cord-blood…
-
anti-obesity medication, Diet & Nutrition, Drugs, effort moralization, GLP-1, medication stigma, moral judgment, obesity stigma, Ozempic, Psychology, semaglutide, social psychology, Wegovy, weight stigma, Weight-loss drugsGLP-1 Weight-Loss Drugs Triggered Effort-Based Stigma in 4 Studies
A 2026 Scientific Reports paper involving 1,205 participants found that people using…
-
addiction, adolescents, alcohol, Cannabis, Drugs, meta-analysis, prevalence, Prevention, public-health, South Africa, substance use, tobaccoTeen Substance Use in South Africa: 30-Study Meta-Analysis
A 2026 PRISMA-compliant systematic review and meta-analysis in Drug and Alcohol Review…
-
Chinese Americans, cognition, cognitive decline, conscientiousness, Dementia, hopelessness, hpa axis, longitudinal cohort, memory decline, Neurodegenerative Diseases, older adults, perceived stress, PINE study, Psychology, StressStress Internalization Predicts Memory Decline in Older Chinese Americans
A 2025 longitudinal analysis of 1,528 older Chinese Americans by Chen et…
-
AD/ADRD, Alzheimer’s disease, APOE-e4, Brain, cardiovascular risk, cognitive decline, Dementia, Drugs, Kaiser Permanente, LDL cholesterol, Neurodegenerative Diseases, observational bias, statins, target trial emulationStatins and Dementia Risk: No Long-Term Signal in 322,358 Patients
Statins do not look like a dementia-prevention drug, but they do not…
-
Brain, cognitive remediation, depression, gamma neuromodulation, GENUS, iTBS, major depressive disorder, meta-analysis, Neurostimulation, schizophrenia, tACS, therapy, theta-burst stimulation, TMS, Tsai labGamma Brain Stimulation Helps Schizophrenia More Than Depression
A 2026 meta-analysis of 56 controlled trials found the clearest gamma-frequency neuromodulation…
-
amygdala, Anxiety, anxiety disorders, associative learning, Brain, cognition, D-cycloserine, diffusion mri, exposure therapy, fear extinction, fMRI, hippocampus, prefrontal cortex, PTSD, therapyResting Brain Connectivity Predicts Fear Extinction Learning
A 2026 multimodal MRI analysis of 509 healthy adults found that fear…
-
addiction, blood pressure, Cannabis, cardiovascular risk, Drugs, Hormones, hypertension, marijuana, nuMoM2b, postpartum health, postpartum mood, self-medication, side effects, thc, women’s healthCannabis After Pregnancy Did Not Increase Hypertension Risk in nuMoM2b
A 2026 nuMoM2b Heart Health Study analysis tested whether urine-confirmed cannabis exposure…
-
ADHD, atomoxetine, cheating behavior, cognitive enhancement, dishonesty, dopamine, Drugs, methylphenidate, Neurotransmitters, norepinephrine, Psychology, ritalin, smart drugs, Stimulants, strattera, striatal dopamineMethylphenidate Reduced Dishonesty and Cheating in 151 Adults; Atomoxetine Had No Effect
A 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology…
